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a b s t r a c t
Control of Johne’s disease, caused by Mycobacterium avium subsp. paratuberculosis, has been difﬁcult
because of a lack of an effective vaccine. To address this problem we used targeted gene disruption to
develop candidate mutants with impaired capacity to survive ex vivo and in vivo to test as a vaccine.
We selected relA and pknG, genes known to be important virulence factors in Mycobacterium tuberculosis
and Mycobacterium bovis, for initial studies. Deletion mutants were made in a wild type Map (K10) and
its recombinant strain expressing the green ﬂuorescent protein (K10-GFP). Comparison of survival in
an ex vivo assay revealed deletion of either gene attenuated survival in monocyte-derived macrophages
compared to survival of wild-type K10. In contrast, study in calves revealed survival in vivo was mainly
affected by deletion of relA. Bacteria were detected in tissues from wild-type and the pknG mutant infected
calves by bacterial culture and PCR at three months post infection. No bacteria were detected in tissues
from calves infected with the relA mutant (P < 0.05). Flow cytometric analysis of the immune response
to the wild-type K10-GFP and the mutant strains showed deletion of either gene did not affect their
capacity to elicit a strong proliferative response to soluble antigen extract or live Map. Quantitative RTPCR revealed genes encoding IFN-␥, IL-17, IL-22, T-bet, RORC, and granulysin were up-regulated in PBMC
stimulated with live Map three months post infection compared to the response of PBMC pre-infection. A
challenge study in kid goats showed deletion of pknG did not interfere with establishment of an infection.
As in calves, deletion of relA attenuated survival in vivo. The mutant also elicited an immune response that
limited colonization by challenge wild type Map. The ﬁndings show the relA mutant is a good candidate
for development of a live attenuated vaccine for Johne’s disease.
© 2011 Elsevier Ltd. All rights reserved.

1. Introduction
Mycobacterium avium subsp. paratuberculosis (Map) is a
pathogen with a broad-host range (reviewed in [1]). Although it
can infect multiple species including humans [2,3], it is primarily
a disease problem in ruminants. It is the causative agent of Johne’s
disease (JD). The prevalence in U.S dairy herds is estimated to be
68% according to the most recent report from the National Animal
Health Monitoring System [4]. A growing concern, however, is that
Map from dairy cattle may also present a threat to individuals at
risk for developing Crohn’s disease (CD), a form of inﬂammatory
bowel disease [5]. Map has been identiﬁed in tissues from children
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[6,7] and adults with CD [8]. The higher frequency of detection of
Map [2,3] and the presence of Map antigen (Ag) speciﬁc T cells [9]
in ileal tissues from patients with CD supports the supposition that
Map may be a contributing factor in CD pathogenesis. Additional
evidence supporting the supposition may be the observation that
childhood intestinal tuberculosis, caused by Mycobacterium tuberculosis (Mtb), has been occasionally misdiagnosed as CD [10]. These
observations emphasize the importance of developing a strategy to
control Johne’s disease (JD) for the livestock industry and human
health.
JD has been difﬁcult to control because of a limited understanding of the mechanisms of pathogenesis and the lack of a vaccine
that prevents establishment of a persistent infection. When cattle are exposed to Map, they initially develop an immune response
that controls but does not eliminate the pathogen. Efforts to overwhelm the response by exposing young calves to single and serial
This article is a U.S. government work, and is not subject to copyright in the United States.
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doses of up to 108 bacteria by the oral route or directly through an
indwelling cannula to accelerate disease progression have shown
the immune response is resilient and not readily suppressed
[11,12]. Similar results have been observed with calves inoculated
with up to 1012 bacteria and treated with dexamethasone [13]. An
immune response to Johnin puriﬁed protein derivative (jPPD) and
soluble antigens (SAg), dominated by CD4 memory T cells, become
consistently detectable two months post infection (PI). A less vigorous CD8 memory T cell response occurs during the same time
frame becoming more pronounced one year PI. Both NK and ␥␦
T cells become activated but activation appears to be nonspeciﬁc
[12]. Over time, however, persistent infection triggers an event that
dysregulates protective immunity and allows disease to progress in
some animals, usually 2 or more years PI. This latent stage of infection is similar to latency in tuberculosis (TB). Studies conducted
thus far in TB and JD have not identiﬁed the triggering event. However, investigations in M. tuberculosis (Mtb) indicate dysregulation
is associated with the capacity of pathogenic mycobacteria to establish a persistent infection in dendritic cells (DC) and macrophages
[14–16] and modulate secretion of IL-12 and IL-23, cytokines that
play a pivotal role in driving the differentiation of naïve CD4 and
CD8 T cell subsets with effector activity (Th1, Th2, Th17 and Th22
cells) or regulatory activity (regulatory T cells, Tr cells) [17–21].
Th17 and Th22 cells are the source of newly identiﬁed proinﬂammatory cytokines IL-17 and IL-22, granulysin (a mycobactericidal
peptide), and IFN-␥, the cytokine that primes DC for initiation
of adaptive immunity [22–25]. Dysregulation of cytokine signaling from infected cells could be the triggering event. Studies in
humans and mice suggest dysregulation of cytokine signaling leads
to induction of regulatory T (Tr) cells that modulate the response
to Mtb and contribute to the activation of Mtb in latently infected
subjects [26,27]. It is postulated that Tr play a similar role in modulating the immune response to Map [28]. Regardless of where the
triggering event occurs it is clear that a vaccine must block the
capacity of Map to establish an infection.
Killed vaccines have proven useful in limiting disease progression and more recently have shown potential as a therapeutic agent
[29,30]. However, they have not been effective in preventing infection [31]. Similar results have been obtained recently with subunit
vaccines, emphasizing the potential and limitation of such vaccines for controlling JD [32]. The inability of killed and subunit
vaccines to prevent establishment of infection leaves the potential
for infected animals to break with disease if protective immunity
wanes [31]. Further studies are clearly needed to determine if a
vaccine can be developed that elicits an immune response that
prevents establishment of a persistent infection. Because of the
issues with killed and peptide based vaccines interest has increased
in the potential of developing genetically attenuated mutants for
evaluation as vaccines for JD. This strategy has been successful
for other pathogens. Large libraries of mutants have been developed by transposon mutagenesis and are currently being screened
to identify candidates for evaluation [33–35]. The sequencing of
the Map genome, however, has provided an opportunity to take a
more direct approach to developing mutants. To take advantage of
this approach, we adapted the method of targeted allelic exchange
mutagenesis for use with Map [36]. Three orthologues of genes
associated with virulence or function in Mtb and Mycobacterium
bovis (Mbv), relA and pknG [37,38], and lsr2 [39], were initially
selected and successfully disrupted in the study.
The general procedure currently in use to evaluate deletion
mutants of Map for potential as a vaccine has been to initially screen
for attenuation in macrophages ex vivo on the premise that attenuation would be an indicator of how a mutant would survive in vivo.
Based on the same premise, the mouse model has been selected for
further evaluation of vaccine potential. The goat model has been
selected for use in the ﬁnal evaluation of candidate vaccines for

efﬁcacy (reviewed in [40]). Since we have been interested in determining the effect of mutation on the immune response to candidate
vaccines as well as attenuation, we have focused on using the natural hosts of Map in our studies. We developed a ﬂow cytometric
assay and the monoclonal antibody reagents needed to study the
immune response in cattle [11,12]. We also developed a cannulated
ileum model to provide continuous access to the ileum and means
for studying the effect of vaccination on survival of challenge bacteria [11]. The objectives of the present study were to evaluate the
effect of deletion of two of the candidate genes, relA and pknG, on
survival ex vivo in macrophages and in vivo in calves and goats and
also determine whether gene deletion affected the capacity of the
mutant to elicit an immune response. We were especially interested in whether cells producing IL-17, IL-22, and granulysin were
involved in the response to the mutant and wild type Map.
2. Materials and methods
2.1. Preparation of bacteria
A clinical isolate of wild-type Map strain, K10Wt , and its
derivative expressing green ﬂuorescence protein, K10Wt -GFP, were
generously provided by Raul Barletta, University of Nebraska, Lincoln, NE [41]. The deletion mutants of K10Wt (K10pknG and K10relA )
and K10Wt -GFP (K10pknG -GFP and K10relA -GFP) used in this study
were previously generated in our laboratory [36]. Each strain was
enriched from a single colony in Middlebrook 7H9 medium (Difco)
supplemented with 6.7% para-JEM GS (Trek Diagnostic Systems,
OH), 2 g/ml of mycobactin J (Allied Monitor, MO), and 0.05%
Tween 80 (7H9 broth medium) [36]. When the broth culture
reached an OD600 of 0.6–0.8, master stocks were prepared in 1.5 ml
microcentrifuge screw-cap tubes, stored at −80 ◦ C, and used for
each infection as previously described [11]. The bacterial numbers
were estimated based on the OD600 values [36].
2.2. Calves
Fifteen newborn Holstein bull calves were obtained from the
Washington State University research dairy. The dairy is a closed
herd that is considered to be free of paratuberculosis. The dairy has
no history of paratuberculosis for over 30 years and performs periodic whole-herd ELISA screening tests to verify disease free status
[11]. All calves were fed 4 L of maternally derived colostrum within
6 h of birth, and taken to a Biosafety Level 2 (BL-2) isolation unit
within the ﬁrst 24 h of life. Calves were fed milk replacer, whey
pellets, calf starter grain, and free choice alfalfa hay. All protocols
and procedures were approved by the Washington State University
Institutional Animal Care and Use Committee.
2.3. Ileal cannulation and inoculation of calves
Calves were raised in isolation facilities for 8–9 wks until they
were weaned from milk replacer and deemed to be large enough for
surgery. Then animals were divided into three groups for different
Map strain infection: K10relA -GFP (n = 6), K10pknG -GFP (n = 6), and
K10Wt -GFP (n = 3). The surgical procedure and post surgical care
were performed as described by Allen et al. [11]. A calf in each
mutant group was lost due to unexpected death.
Two weeks post surgery, the calves were inoculated with wildtype or mutant strains of Map (109 CFU in 20 ml of PBS) directly
into the ileum. This was accomplished by inserting a French Foley
catheter into the cannula and inﬂating it to block ﬂow of ingesta.
The catheter was left in place for 1 hour to allow the inoculum to
remain in contact with ileal tissue. Each group of calves was housed
in a separate isolation building to prevent cross infection. Fecal
samples were collected at 1 wk before infection, and 24 h, 2, 6, and
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12 wks PI to screen for bacterial shedding. The feces were stored at
−20 ◦ C until processed. All fecal samples collected before infection
were PCR negative. All infected animals were euthanized at three
months PI as described [11].
2.4. Blood processing and isolation of peripheral blood
mononuclear cells
Blood was collected from calves before inoculation, at 8 wks
PI, and at the time of necropsy (three months PI). Peripheral
blood mononuclear cells (PBMCs) were isolated as previously
described [11]. Isolated PBMCs were re-suspended in RPMI-1640
medium supplemented with 10 mM HEPES, 13% bovine calf serum
(BCS), 2-mercapto ethanol, 20 mM l-glutamine, and antibiotics
(100 units/ml of penicillin G and 100 g/ml of streptomycin sulfate), and then used as described.
2.5. Preparation and infection of bovine macrophages with Map
Bovine monocyte-derived macrophages (M) were prepared
in 24 well tissue culture plates as previously described [42]. The
differentiated M (approximately 105 cells/well) were infected
with each Map strain at a multiplicity of infection of 10 for 3 h.
Extracellular bacteria were removed by washing three times with
warm RPMI-1640. Infected macrophages were lysed immediately
(deﬁned as day 0) or cultured in RPMI-1640 medium without
antibiotics for 6 days (deﬁned as day 6). Macrophages were lysed
with 0.1% saponin in PBS, and the lysates were plated in10-fold
dilutions on 7H9 agar plates to determine the number of bacteria.
The experiments were performed in triplicate and repeated two
times.
To compare transcription of cytokines in infected cells, additional bovine M were prepared in 60 mm-diameter tissue culture
plates (Becton Dickinson), and infected as described above. At 6 h
and 24 h PI, the culture medium was removed and M were lysed
in 1 ml of Trizol (Invitrogen). Total RNA was extracted from cells
according to the manufacturer’s instructions.
2.6. Map culture and tissue sample processing
Nine different tissue sites of the intestine and lymph nodes were
obtained at the time of necropsy. The method for culturing Map
from tissues was slightly modiﬁed from a previous method [43].
In brief, 1.5 g of tissue were homogenized in a 15 ml Closed Tissue Grinder System (Fisher Scientiﬁc) in 15 ml of distilled water.
The homogenates were allowed to stand for 30 min. Supernatant
(7 ml) was transferred into a new 15 ml tube. Two microliters of
the supernatant was taken and distributed into two 2 ml screw-cap
tubes (1 ml for each). The tubes were centrifuged at 15,000 × g for
15 min. The pellets were stored at −20 ◦ C for identiﬁcation of Map
DNA by real-time PCR (RT-PCR). The remaining 5 ml of supernatant
was decontaminated by mixing with the same volume of 1.5% hexadecyl pyridinium chloride and incubated overnight. The tube was
centrifuged at 3800 × g for 30 min with no brake. The pellet was
resuspended in 1 ml of 7H9 broth medium supplemented with 1.9%
para-JEM AS (antibiotic solution containing vancomycin, amphotericin B, nalidixic acid) (Trek Diagnostic Systems, OH). Three 7H9
agar plates containing 1.9% para-JEM AS were inoculated with
0.2 ml of the re-suspended pellet. The cultures were incubated at
37 ◦ C for 14–16 wks.
2.7. Extraction and RT-PCR identiﬁcation of Map DNA from tissue
and fecal samples
The frozen tissue pellets were pre-treated in 360 l of tissue lysis buffer (ATL buffer, Qiagen) and 40 l of protein kinase
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(>600 mAU/ml, Qiagen) at 56 ◦ C for 1 h. Tubes were then centrifuged at 15,000 × g for 15 min, and the supernatant carefully
removed using a 1 ml pipette tip. The remaining steps for DNA
extraction were performed with the DNeasy Blood and Tissue kit
(Qiagen) following a protocol for Gram-positive bacteria. During
the lysis steps in the protocol, the bacteria were mechanically disrupted with 0.1-mm zirconia-silica beads (BioSpec Products Inc.,
OK) in FastPrep-24 instrument (MP Biochemicals, CA) to facilitate
DNA release. DNA was eluted in 200 l of AE buffer.
Fecal DNA was extracted, in duplicate, using a method described
by Schonenbrucher et al. [44]. The lysing matrix D tube used in the
original study was replaced with a 2 ml screw-cap tube containing
200 l of 0.1-mm zirconia-silica beads.
RT-PCR detection of the IS900 sequence was performed using a
StepOnePlus Real-Time PCR System machine (Applied Biosystems,
CA). Five microliters of eluted DNA sample was used in ﬁnal 25 l of
reaction mixture. The RT-PCR conditions and sequences for primer
and probe were the same as previously described [45]. Each sample
was run in duplicate.
2.8. PBMC stimulation with live Map and Map antigens
PBMCs (107 ) were distributed into 6-well culture plates. Each
well was prepared to contain 5 × 106 CFU of live Map K10, 20 g of
Map SAg, or none (“nil” treatment) in 5 ml of RPMI-1640 medium as
previously described [11]. Identical plates were prepared for each
of the experimental procedures. PBMCs stimulated with live Map,
Map SAg, or medium alone were collected from three identical wells
on day 6, and used for ﬂow cytometric analysis (FC).
To compare the level of cytokine transcriptions between PBMCs
isolated from calves before and after infection, three identical plates
for live Map stimulation or un-stimulated (control) were set up in
24-well plates. After 3 days incubation, total RNA was extracted
from the pooled PBMCs in triplicate.
2.9. Flow cytometric analysis of stimulated PBMCs
FC analysis was conducted as previously described [11]. The
strategy used for FC analysis is shown in Fig. 1. PBMCs cultured
for 6 days with/without Ag stimulation were labeled with a three
color combination of monoclonal antibodies: CD4 (ILA11A, IgG2a),
CD45R0 (ILA116A, IgG3), and CD25 (CACT116A, IgG1), or CD8
(7C2B, IgG2a), CD45R0, and CD25. The percent activated CD4 or CD8
memory T cells in total CD4 or CD8 T-cell pool was determined by
using electronic gates to isolate CD4 and CD8 populations for analysis. Electronic gates, placed on small un-activated (resting) and
large activated (proliferating) cells based on side-scatter (SSC) vs.
forward-scatter (FSC), were used to track the proportion of activated cells in the culture as previously described [11]. Data were
collected with Cell Quest software (Becton Dickinson Immunocytometry Systems, San Jose, CA) from a FACSort ﬂow cytometer, and
analyzed with FCS Express software (De Novo software, Thornton,
Ontario, Canada).
2.10. Relative quantiﬁcation of cytokine transcription
Quantitative reverse-transcription RT-PCR (qRT-PCR) was performed using extracted RNA (see above). The extracted RNA
was treated with Turbo DNA-free kit (Applied Biosystems, TX)
to remove genomic DNA contamination. RNA was reverse transcribed to cDNA using High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, CA) according to the manufacturer’s
instructions. The reaction mixture was prepared in a total of
20 l containing 1× Power SYBR Green PCR Master Mix (Applied
Biosystems, CA), 200 nM of each primer, and cDNA. The qRT-PCR
was performed in a StepOnePlus Real-Time PCR System machine
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Table 1
Primers used for qRT-PCR quantiﬁcation for cytokine transcription.
Gene

Forward primer

Reverse primer

Sourcea

␤-Actin
GAPDH
IL-10
IL-12p35
IL-17
IL-22
IL-23p19
Granb
Foxp3
IFN-␥
T-bet
TGF-␤
TNF-␣
RORC

GGAATCCTGCGGCATTCAC
GCATCGTGGAGGGACTTATGA
GAGCAAGGCGGTGGAGAAGG
CAGCAAGCCCAGGAAGGA
GGACTCTCCACCGCAATGAG
GAGGTGCTGTTCCCCCAAT
CACAAGGACTCAGGGACAACAG
GACCTGCTGCTCCAAGGAGAA
CCGGCATGCCTAGGAAAGA
CTTGAATGGCAGCTCTGAGAAA
GAGGCGGCCTGCAACAC
CATCTGGAGCCTGGATACACAGT
TCTACCAGGGAGGAGTCTTCCA
GAGTGCCTTGCGCTTTTCA

GGATGTCGACGTCACACTTCA
GGGCCATCCACAGTCTTCTG
GATGAAGATGTCAAACTCACTCATGG
TGACAGCCCTCAGCAGGTTT
TGGCCTCCCAGATCACAGA
GAAGGGCACCACCTTTTCC
AAAAACCAGGCCTCGATGAA
CCAACTTGTCCATCAGATGTTGTATT
ACGCCATTTGCTAGCAGTGAGT
TGCAGATCATCCACCGGAAT
CGGCGATGAACTGGGTTT
GAAGCGCCCGGGTTGT
GTCCGGCAGGTTGATCTCA
GATGAGGACGAGGGCTGTG

NM173979
[59]
NM174088
NM174355
NM001008412
NM001098379
XM588269
NM001075143
DQ322170
[60]
XM583748
[60]
[61]
DQ667051

a
b

Gene Accession No. is given for the primers developed in this study.
Granulysin.

(Applied Biosystems, CA) under the following conditions: 95 ◦ C for
10 min, 40 cycles of 95 ◦ C for 15 s and 60 ◦ C for 1 min, followed
by a dissociation analysis. The relative quantiﬁcation (RQ) of gene
transcription was analyzed using Step One software v2.1 program
(Applied Biosystems, CA) by the 2−(Ct) method [46]. Brieﬂy, Ct
of each gene was calculated based on the mean Ct value of the
two housekeeping genes (␤-actin and GAPDH). Then, Ct was
calculated using appropriate control groups as the calibrators (unstimulated M, un-stimulated PBMCs, or Map-stimulated PBMCs
before infection). The results were expressed as relative quantiﬁcation of transcription compared to those of control groups.
The primer sequences used in this study are listed in Table 1.
The primers developed in this study were designed using Primer
Express 3.0 (Applied Biosystems, CA).

2.11. Goat challenge study
Thirteen newborn goats were obtained from the goat herd maintained by the USDA-ARS unit at Washington State University. It has
been maintained as a closed herd for 30 years. No animals have been
diagnosed with JD during this time. All of the goats were maintained
in a barn with concrete ﬂoor pens. All protocols and procedures
were approved by the Washington State University Institutional
Animal Care and Use Committee.
One goat (Y23) was euthanized, and tissue samples were collected. Fecal samples from all animals before inoculation were also
collected. All tissue and fecal samples collected before inoculation
were Map culture negative. The remaining goats (∼8 months of
age when used) were divided into four groups of 3 for the study
and moved to separate BL-2 holding facilities for the duration of
the studies. One group each was orally inoculated per os with 109
K10pknG , K10relA , or K10Wt . One group was not inoculated until
the time of challenge. After 2 months, all groups were challenged
with 109 K10Wt by oral route. All of the goats were euthanized
and necropsied at 2 months post challenge. Tissues were collected
and processed for bacterial culture as described above. Each 0.2 ml
of the ﬁnal re-suspension was inoculated on 7H9 agar plate with
or without hygromycin (75 g/ml), in duplicate, to distinguish the
CFU originated from mutant or wild-type strains.
2.12. Statistical analysis

Fig. 1. Gating strategy used to determine the frequency of activated CD4 memory T
cells. Electronic gates 1 and 2 were placed on small unactivated and large activated
cells (SSC vs. FSC) and color coded to identify T cells proliferating in response to
antigen stimulation (A). An additional electronic gate was used to isolate CD4 T cells
to determine the frequency of CD45R0/CD25+ CD4 memory T cells proliferating in
response to antigen stimulation (B). (C) Shows the frequency of activated CD4 memory T cells (FSC vs. CD45R0). (D) Shows that resting and activated CD4 memory T
cells express CD25. A combination of electronic gates placed on small unactivated or
activated CD4 T cells, (E) and (F), respectively, were used to show that only unactivated and activated memory T cells express CD25. No naïve CD4 cells express CD25
(lower left quadrant in E). All activated memory CD4 T cells express CD25 (F). This
observation has allowed us to use FSC vs. CD45R0 to determine the frequency of
activated CD4 memory T cells (C). The same gating strategy was used to determine
the frequency of activated memory CD8 cells.

All statistical analyses were performed using MedCalc statistical software ver. 11. 2. 1 (Belgium). For comparison of intracellular
survival of Map strains, the CFU data on day 6 were normalized
by transforming to the percent survival, based on the CFU present
at day 0. The results of survival rate of mutants and the relative quantiﬁcation of gene transcription were analyzed using the
Kruskal–Wallis test or one-way ANOVA. The numbers of Map culture positive animals between groups were compared by Fisher’s
exact test. In all tests, a P value of less than 0.05 was considered
signiﬁcant.
3. Results
3.1. Survival of Map mutants in bovine M
The number of wild-type and mutant Map in M was determined on days 0 and 6, and the survival rate of each strain on day
6 was calculated using the CFUs obtained on days 0 and 6. The survival rate of all Map strains decreased on day 6 compared to those at

K.T. Park et al. / Vaccine 29 (2011) 4709–4719

4713

Table 2
Map culture results from 9 tissue sites from calves at necropsy.
Strain

Animal

JP

JM

JD

IP

IM

ID

ICV

ML

ICL

K10Wt -GFP

136
139
151
134
135
137
138
140
145
146
147
148
149

−a
−
−
−
−
−
−
−
−
−
−
−
−

−
−
−
−
−
−
−
−
−
1
−
−
−

−
11
−
−
−
−
−
−
−
−
−
−
−

−
−
−
−
−
−
−
−
−
690
1
−
−

5b
125
2
−
−
−
−
−
−
410
5
119
−

285
3
−
−
−
−
−
−
−
13
−
1
−

46
−
5
−
−
−
−
−
−
18
−
11
−

3
−
2
−
−
−
−
−
−
−
−
−
−

35
9
7
−
−
−
−
−
−
1
−
−
−

K10relA -GFP

K10pkng -GFP

JP, JM, JD: jejunum proximal, middle, distal; IP, IM, ID: ileum proximal, middle, distal; ICV: ileocecal valve; ML, ICL: mesenteric and ileocecal lymph nodes.
a
Negative.
b
Values are expressed as the total CFU obtained from each tissue.

day 0, but the survival rates of K10pkng (5.1 ± 1.0%; SD) and K10relA
(12.5 ± 6.3%) mutants on day 6 were signiﬁcantly lower than that
of the parental strain (29.4 ± 3.6%) (P < 0.05). In addition, there was
a statistically signiﬁcant difference between K10pkng and K10relA
(P < 0.05) (Fig. 2). These data suggest that the pknG mutant is more
attenuated in bovine macrophages than relA in comparison to the
wild-type strain.

3.2. Comparison of cytokine gene transcription in M infected
with wild-type and mutant strains of Map
The transcription levels of IL-10, TNF-␣, IL-12p35, and IL-23p19
in bovine macrophages were measured by qRT-PCR at 6 and 24 h PI
to determine the effect of infection on cytokine expression (Fig. 3).
The expression of all 4 cytokines increased to some degree following infection, but signiﬁcant differences were only observed for
TNF-␣ and IL23 in all infected M groups compared to those of
uninfected MФ at 24 h PI. While IL-23 transcription was strongly
elevated in response to all the Map strains, the transcription of
IL12p35 was only slightly changed. There were, however, no significant differences found between M infected with wild-type and
mutant strains for the cytokines measured in this study.

3.3. Map culture and RT-PCR identiﬁcation in animal tissues and
fecal samples
All three K10Wt -GFP infected calves were bacterial culture positive at necropsy, but only three of ﬁve K10pkng -GFP infected calves
were positive at necropsy. All ﬁve K10relA -GFP infected calves
were culture negative (Table 2), which was statistically signiﬁcant (P < 0.05). The mean percentages of Map culture positive tissue
were 48.1% (28.7–68.1, 95% CI) for K10Wt -GFP, 24.4% (12.9–39.6)
for K10pkng -GFP, and 0% (0–7.87) for K10relA -GFP infected groups,
respectively (Table 2). Screening for the presence of Map DNA
by RT-PCR yielded results consistent with the culture results
(kappa = 0.74). Seven tissues, deﬁned as positive by Map culture,
were negative by RT-PCR, but two negative tissues deﬁned by Map
culture were positive by RT-PCR. Six of the seven false negative
tissues with RT-PCR had low colony counts (the sum of the CFUs
from the triplicate plates was 5 or fewer). Importantly, none of the
tissues from K10relA -GFP infected group were positive by RT-PCR.
Fecal Map-PCR results revealed that all infected animals had passive bacterial shedding at 24 h PI. One or more animals in each group
was fecal Map-PCR positive at 2 wks PI. After 2 wks, only one of the
K10pknG -GFP group and one of the K10Wt -GFP group were positive
by fecal Map-PCR at 6 and 12 wks PI, respectively (Table 3).
3.4. Flow cytometric analysis of PBMC from calves stimulated
with live Map or Map SAg
The FC results with PBMC stimulated with live Map or Map SAg
showed speciﬁc memory response against live Map and Map SAg
after inoculation. The percentage of activated CD4 and CD8 memory
T cells increased in response to stimulation with live Map and Map
SAg until necropsy in the wild-type Map infected group (Fig. 4A).
Remarkably, live Map elicited a more vigorous CD4 and CD8 T-cell
proliferative response than Map SAg. In addition, the CD8 T-cell
response was much higher for live Map than the CD4 T-cell response
at 12 wks PI.
Overall, the memory T-cell response to the relA mutant infected
group was similar to that of the wild-type Map infected group,
Table 3
Real-time PCR detection of IS900 in calve fecal samples.

Fig. 2. Survival of wild-type and mutant strains of Map in macrophages. Bovine
macrophages were infected with wild-type or mutant Map strains. The bacterial
numbers were counted on days 0 and 6. The percent survival of each strain on day
6 was calculated based on the CFU taken at day 0. The results are represented as
the mean percent survival of each strain with error bar (SD) from two independent
experiments (each in triplicate). * and , signiﬁcant decrease compared to K10Wt
and K10relA , respectively (P < 0.05).

Group
K10Wt -GFP
K10relA -GFP
K10pknG -GFP

24 h
a

3/3
5/5
5/5

2 wks

6 wks

12 wks

1/3
2/5
2/5

0/3
0/5
1/5

1/3
0/5
0/5

a
Values are expressed as the number of positive calves/the number of tested
calves.
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Fig. 3. Transcription of cytokines in bovine macrophages infected with wild or mutant Map strains. Total RNA was extracted from macrophages after 6 and 24 h infection, and
the relative quantiﬁcation of cytokine transcription was measured by qRT-PCR. The relative quantiﬁcation of gene transcription was calculated using uninfected macrophages
(nil control) as calibrator by 2−(Ct) method. Two housekeeping genes (␤-actin and GAPDH) were used as controls. Data are shown as the mean of two independent duplicated
assays. Error bar indicates standard error. *, signiﬁcant difference compared to the cytokine transcription in nil control (P < 0.05).

Fig. 4. Comparison of memory T cell response in PBMCs isolated before and after infection by ﬂow cytometric analysis. The data are presented as the mean percent (with SE)
of activated CD4 or CD8 memory T cells in response to Map antigen stimulation or nil treatment at different time points. Pre, pre-infection; Nil, nil-stimulation; SAg, soluble
anigen stimulation; Map, live Map stimulation; *, signiﬁcant difference compared to the value of nil control (P < 0.05).

K.T. Park et al. / Vaccine 29 (2011) 4709–4719

4715

Fig. 5. Relative transcription of cytokines in PBMCs in response to live Map stimulation measured by qRT-PCR. PBMCs isolated at pre-infection and necropsy were simulated
with live Map for 3 days. The relative transcription was calculated using the value at pre-infection as the calibrator with two housekeeping genes (␤-actin and GAPDH). Data
are presented as the mean value of each group with error bar (SD). RQ, relative quantiﬁcation; *, signiﬁcant difference compared to the value at pre-infection (P < 0.05).

although the peak was reached at 8 wks PI, and persisted until
necropsy. Signiﬁcant differences compared to un-stimulated PBMC
were observed only when stimulated with live Map (both 8 and
12 wks PI). The CD8 T-cell response against live Map stimulation
was also more vigorous than the CD4 T-cell response (Fig. 4B). The
pattern of memory T-cell response of the pknG mutant infected
group was similar to that of the relA mutant infected group. However, as noted in a previous study, there was a high response to live
Map and Map SAg at pre-infection (Fig. 4C) [11].
3.5. Cytokine transcription in PBMCs stimulated with live Map
Relative changes of cytokine transcription in PBMCs stimulated for three days with live Map were compared between two
time points (pre-infection vs. necropsy) by qRT-PCR. The K10pknG
infected group was excluded from this analysis due to the unexpected high responsiveness to Map SAg at pre-infection. The data
have been grouped to compare the cytokine proﬁles considered to
deﬁne Th1, Th17, and regulatory T cells (Treg).

The general proﬁles of transcriptional change of cytokine
expression between pre-infection and three months PI were similar
in the K10Wt and K10relA groups. The transcription of IFN-␥, an indicator of a Th1 response, was elevated signiﬁcantly in both K10Wt
and K10relA infected groups (mean fold changes: 896 and 106,
respectively). The transcription factor, T-bet, was also increased
(Fig. 5A). Cytokines secreted by Th17 cells, IL-17 and IL-22, were
also up-regulated in both infected groups at three months PI. While
the transcriptional changes of the two cytokines were signiﬁcant
in the K10relA infected group (P < 0.05), they were not signiﬁcant
in the K10Wt infected group. A transcription factor for Th17 cells,
RORC, was simultaneously up-regulated in both groups (Fig. 5B).
Regulatory cytokines secreted by Treg, IL-10 and TGF-␤, and a
transcription factor, Foxp3, were not changed or were slightly
decreased in the level of transcription at three months PI compared
to those at pre-infection (no signiﬁcant changes in both experimental groups, P > 0.05) (Fig. 5C).
Stimulation with live Map induced expression of granulysin
mRNA in PBMCs from calves before infection (mean, 4.4- to 6.6-
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4. Discussion

Fig. 6. Relative transcription of granulysin mRNA. PBMCs isolated at pre-infection
and necropsy were cultured with live Map or medium alone (nil treatment) for
3 days. The level of mRNA transcription was measured by qRT-PCR. The relative
quantiﬁcation of mRNA transcription was calculated using a calibrator (nil-treated
PBMCs at pre-infection) and 2 housekeeping genes (␤-actin and GAPDH). Data are
shown as the mean fold changes with error bars (SD). RQ, relative quantiﬁcation;
Pre, pre-infection; Nec, necropsy; Nil, nil-stimulation; Map, live Map stimulation.

fold change). Nevertheless, larger differences in expression of
granulysin mRNA were observed when compared to the same
treated PBMCs from naïve (before infection) and infected calves
(at necropsy). Un-stimulated PBMCs isolated at necropsy produced
signiﬁcantly higher amounts of granulysin mRNA compared to
expression in PBMCs isolated before infection (P < 0.05 for both
infected groups). The increased level was higher in the K10Wt
infected group (mean, 186.2-fold change) than in K10relA mutant
infected group (mean, 18.2-fold change). This increase in transcription of granulysin mRNA in PBMCs from infected calves was
further increased when stimulated with live Map. The mean fold
change (Map stimulation compared to un-stimulation) in PBMCs
from infected calves was 3.7-fold for the wild-type infected group
(not signiﬁcant, P > 0.05) and 15.5-fold for the mutant infected
group (signiﬁcant, P < 0.05), respectively (Fig. 6).

3.6. Effect of exposure to K10pknG and K10relA mutants on survival
of K10Wt in goats
The ﬁndings with calves suggested one of the mutants might
be a candidate for further evaluation as a vaccine. To pursue this
possibility, a pilot study was conducted with a smaller ruminant
animal, goats, to determine if the immune response elicited by
either mutant blocks or diminishes the capacity of K10Wt to establish an infection. As shown in Table 4, the goats exposed two times
with K10Wt at two month interval had more culture positive tissues
and higher bacterial numbers than those observed from animals
only exposed once at the time of challenge. Interestingly, inoculation with the K10pknG mutant before challenge resulted in an
increase in the number of culture positive tissues and bacterial
burden in comparison with tissues from goats exposed once or
twice to K10Wt . The frequency of colonies growing in the presence
and absence of hygromycin indicate most of the colonies obtained
from doubly infected goats were K10pknG mutants. This ﬁnding differs from results obtained in calves that were only exposed to the
K10pknG mutant. In contrast, no K10relA mutants were cultured from
any of the tissues from goats inoculated with the K10relA mutant and
challenged with K10Wt . In addition, inoculation with K10relA attenuated colonization with K10Wt . K10Wt were only cultured from a
single tissue from each goat pre-exposed to K10relA (Table 4).

The present study was designed to determine the effect of gene
disruption on (1) ex vivo and in vivo survival of Map and (2) the
capacity of mutants to elicit an immune response as determined by
ﬂow cytometry and gene expression proﬁles. The results revealed
that deletion of relA, but not pknG, altered the capacity of the
mutants to establish an infection without altering its capacity to
elicit an immune response. In addition, gene expression proﬁles
of T-cell secreting cytokines and granulysin demonstrated similar
proﬁles regardless of infection with relA or wild-type Map. To our
knowledge, this is the ﬁrst demonstration of a mutation in Map that
affects in vivo survival while retaining the capacity to elicit a strong
response to challenge exposure to wild type Map.
Improvement in the use of targeted gene disruption in Map has
allowed us to take a more direct approach to developing a vaccine
that elicits an immune response while blocking the capacity of the
pathogen to evade immune elimination and establish a persistent
infection. The improvement has permitted us to select genes for
disruption that might alter intracellular survival without affecting immunogenicity [36]. Orthologues of two virulence genes in
Mtb and Mbv were selected for initial evaluation. The relA gene
is a global regulator of the stringent response in many bacteria,
including pathogenic mycobacteria. Deletion of relA in Mtb was
shown to decrease the capacity of the mutant to survive in vivo
in a mouse model [37]. Protein kinase G (encoded by pknG) is
secreted by Mtb and BCG-Mbv within the phagosome. pknG inhibits
phagosome–lysosome fusion. Deletion of the gene in BCG-Mbv was
shown to signiﬁcantly decrease survival in M suggesting deletion
would also impair survival in vivo [38]. However, examination of
survival in calves and goats, as noted in the present study, showed
survival in macrophages didn’t predict survival in vivo.
Initial screening of the mutants in an ex vivo MФ assay revealed
deletion of either gene reduced the capacity of Map to survive
in comparison to wild-type Map at 6 days PI. Between the two
mutants, the decrease in survival rate of K10pknG was more significant than that of K10relA (Fig. 2). Although the results from the
pknG deletion mutant were expected [38], the results obtained
with the relA mutant differed from a previous study of the Mtb
relA mutant [47]. In the Mtb study, no difference was observed
in growth rate between the relA mutant and wild-type Mtb in a
human M cell line. The authors suggested that it is because the
primary carbon source for intracellular growth of Mtb depends on
lipid catabolism. Recent studies provide a possible explanation for
our ﬁnding whereby mycobacteria may encounter an inorganic
phosphate limited condition in M, which could induce a stringent response [48–50]. In addition, the decrease in survival in MФ
has also been observed with relA deletion in other intracellular
pathogens [51]. In contrast to the ex vivo studies, the in vivo experiments revealed deletion of relA had a greater effect than deletion
of pknG. All tissues from the K10relA infected calves were negative as assessed by culture and RT-PCR (Table 2) whereas some
tissues from the K10pknG infected group were still positive at three
months PI in some animals. Based on the ex vivo ﬁndings in M with
BCG-Mbv [38] and Map (in this study) this ﬁnding was unexpected.
Nevertheless, the lower frequency of tissue positive sites in K10pknG
infected group compared with the K10Wt infected group indicates
deletion may have had some effect. This difference between the ex
vivo and in vivo results emphasizes the importance of an in vivo
assay to identify mutants for further analysis.
Further analysis showed the deletion of either gene did not alter
the capacity of mutant to induce effector memory T-cell responses.
The FC results revealed that a strong proliferative T-cell response
is elicited against live Map and Map SAg following infection with
wild-type and mutant strains of Map. As noted in previous studies,
the CD8 T-cell proliferative response was less vigorous than the CD4
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Table 4
Map culture results from 9 tissue sites in challenged goats.
Pre-exposure

Challenge

Goat

JP

JM

JD

IP

IM

ID

ICV

ML

ICL

K10pknG

K10Wt

K10relA

K10Wt

K10Wt

K10Wt

NPe

K10Wt

19
21
33
26
27
30
22
25
20
16
24
31

−a
26/22
0/1
−
−
−
−
−
−
−
−
−

2/1b
−
1/0
−
−
−
−
−
−
−
−
−

0/1
−
1/0
−
−
−
−
−
−
−
−
−

C/Cc
2/1
2/2
−
−
−
−
−
−
6/0
−
−

157/151
6/1
58/49
−
−
−
20/0
15/0
−
−
−
7/0

TN/TNd
64/68
TN/TN
10/0
8/0
−
1/0
22/0
8/0
12/0
−
1/0

192/168
122/123
194/173
−
−
2/0
1/0
−
9/0
−
5/0
2/0

4/3
1/1
1/3
−
−
−
−
3/0
5/0
−
−
1/0

47/32
18/25
40/28
−
−
−
30/0
61/0
110/0
3/0
2/0
−

JP, JM, JD: jejunum proximal, middle, distal; IP, IM, ID: ileum proximal, middle, distal; ICV: ileocecal valve; ML, ICL: mesenteric and ileocecal lymph nodes.
a
Negative.
b
Values are expressed as the total CFU obtained from normal 7H9 agar plates/the total CFU from 7H9 agar plates containing hygromycin.
c
Contamination happened during incubation.
d
Too numerous to count.
e
No pre-exposure.

T-cell response to Map SAg and jPPD during the ﬁrst 3 months PI
[11,12]. This was clearly evident with PBMCs from animals infected
with wild-type and the relA mutant. An additional observation
obtained from this study was the difference in response to live Map.
In contrast to the CD8 T-cell response to Map SAg, the CD8 T-cell
response to live Map was much more vigorous and accounted for a
higher proportion of proliferating cells in the cultures (Fig. 4). The
ﬁnding indicates that only examining the proliferative response
to Map antigens (such as jPPD and SAg) does not fully reﬂect the
immune status of memory CD4 and CD8 T cells and their potential
effector activity against Map.
The proliferative response of PBMC from calves inoculated with
the pknG mutant is more difﬁcult to interpret. The response was
already elevated in most of the calves at the initiation of the study.
The explanation for the elevated response is not clear. The WSU
dairy has not had any cases of JD during the past 30 years and we
have used the dairy as a source of our calves for JD research for 10
years. We have considered two possibilities that might account for
the increase in activity. In spite of efforts to minimize opportunity
for exposure, it is possible that this group of calves was exposed
to environmental mycobacteria. Another possibility, however, is
that activated NK cells could have increased the proliferative activity. We have noted in some of our studies that the proliferative
activity of CD4 and CD8 T cells is increased in cultures containing
activated NK cells ([12] and unpublished observations). We did note
that NK cells were activated and proliferating in cultures obtained
from this group of animals. Although elevated, the proliferative
response noted with the K10pknG treated group was consistent with
the response obtained with K10Wt and K10relA treated groups. The
ﬁndings point to the need to assess the activation status of all subsets when conducting studies in cattle.
Analysis of the cytokine proﬁle in infected MФ also revealed that
deletion of either gene did not alter the capacity of the mutants to
stimulate increased expression of genes encoding cytokines that
drive differentiation of naïve T cells to effector T cells that differentially express IFN-␥, IL-17, or IL-22 [18,19]. Of interest, infection
with K10Wt Map or the mutants increased expression of IL-23 in
macrophages, the cytokine associated with driving differentiation
of Th17 cells [20,52], but not IL-12, the cytokine associated with
driving differentiation of Th1 cells. This observation is consistent
with the ﬁnding in MФ stimulated with Mtb Ags [53].
Comparison of the cytokine proﬁles obtained from PBMCs from
K10Wt and K10relA treated groups cultured with live Map revealed
disruption of relA did not alter the capacity of the mutant to elicit
a response comparable to the response elicited by K10Wt . Expression of IFN-␥, IL-17, and IL-22 and their transcription factors were

elevated while the expression of IL-10, Foxp3, and TGF-␤ were
decreased. This difference in expression is consistent with the presence of effector T cells with immunoprotective activity. The ﬁnding
that IFN-␥, IL-17, and IL-22 are all elevated indicates the proliferating population was comprised of two or more subsets expressing
the respective cytokine genes. No information has been obtained
thus far that demonstrate how many subsets exist in ruminants
that express one or more of the cytokines as noted in other species
[18,19]. Further studies are needed to determine how many of these
new CD4 and CD8 T-cell subsets exist in cattle and the relative contribution of subsets to the transcription proﬁles observed in this
study. The ﬁndings show the response to Map is more complex
and that understanding the immune response to Map will require
development of additional reagents to identify and characterize the
function of T-cell subsets.
Although granulysin is under intensive investigation as a
mycobactericidal peptide that may play a role in control of tuberculosis, it has not been examined for a potential role in control
of JD. Both innate and adaptive immune cells have been shown
to secrete the peptide [22,54–57]. In addition to its broad cytotoxic activity towards bacteria and some types of cancer cells it
is a chemotactic attractant that promotes recruitment and activation of DC and potentiation of antigen-speciﬁc immune responses.
Granulysin gene expression was highly up regulated in live Map
treated cultures of PBMC from animals infected with wild-type
and the relA mutant. A similar result has been reported from BCGMbv vaccinated animals. Due to the increased level of granulysin
gene transcription after vaccination, the authors suggested granulyisn could be a biomarker for the presence of protective immunity
against Mbv [58]. Similarly, the ﬁndings obtained here suggest granulysin could play an important role in host defense against Map.
Attenuation of survival in macrophage ex vivo has been used
as a criterion for selection of mutants for further testing in vivo.
Although the mouse is not the natural host of Map it has been considered the animal model of choice for further selection of mutants
for evaluation in goats or cattle. However, a recent report comparing attenuation in the different models has raised a question as to
whether this is the best approach for identifying candidates for testing in vivo [33]. The ﬁndings indicate survival in macrophages and
the mouse model may not predict survival of mutants in the natural
host or their capacity to elicit a protective immune response. Their
conclusion is that even though screening in macrophage cultures ex
vivo and mice in vivo appears to be an economical approach to narrowing down the strains to be tested for attenuation, the potential
of strains as vaccine candidates can only be assessed in ruminants,
the natural hosts of Map. We have taken this possibility into con-
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sideration in our efforts to develop a live attenuated vaccine. The
challenge trial with goats was a follow-up pilot study to determine
if further studies with either mutant were warranted for evaluation
as a candidate vaccine in ruminants such as cattle. We were particularly interested in determining whether the pattern of in vivo
survival of the mutants would be similar in another species and
also whether the immune response elicited by the mutants would
have any effect on establishment of an infection with K10Wt , In contrast to the calf-infection study, the pknG mutant was detected in
more tissue sites with higher concentration of bacteria in the tissues than detected in tissues from goats inoculated once or twice
with K10Wt , Outgrowth of bacteria was comparable in the presence
and absence of hygromycin indicating the majority of the bacteria
were from the hygromycin marked mutant, K10pknG . This was an
unexpected result based on the previous results in the current study
and others [38]. In contrast, the relA mutant was not able to establish an infection but was able to elicit an immune response that
attenuated the capacity of K10Wt , to establish an infection. A few
K10Wt , were cultured from a single tissue from each animal inoculated with the relA mutant followed by challenge with wild-type
Map. The signiﬁcance of this ﬁnding is that it shows the relA mutant
elicits an immune response that differs from the response elicited
by the pknG mutant and K10Wt . To our knowledge this is the ﬁrst
report showing such a difference. Further studies are needed to elucidate the basis for the difference in the immune response to the
relA mutant and wild-type Map.
In conclusion, the strategies used to identify and evaluate Map
mutants for potential use as a vaccine have yielded a mutant that
meets the criteria for further testing. Disruption of relA attenuated
survival ex vivo in macrophages without altering its capacity to activate cytokine genes comparable to wild-type Map. Disruption also
attenuated survival in vivo in cattle as well as goats. The ﬁndings
suggest deletion of relA blocked the capacity of Map to establish
a persistent infection in DC and macrophages, the cells used by
Map to establish persistent infection and dysregulate protective
immunity.

Acknowledgements
This project was funded in part with funds from the National
Institute of Allergy and Infectious Diseases, National Institutes of
Health, Department of Health and Human Services, under Contract No. N01-AI-30055, the JDIP program (USDA-CSREES-NRI-CAP
Award No. 2007-01019) awarded to WCD, USDA-APHIS 03-91000788-GR and 03-9100-07-GR, and an intramural grant USDA
Animal Health WNV-00150 and the WSU Monoclonal Antibody
Center.

References
[1] National Research Council (U.S.). Committee on diagnosis and control of Johne’s
disease. Diagnosis and control of Johne’s disease. Washington, D.C.: National
Academies Press; 2003.
[2] Juste RA, Elguezabal N, Pavon A, Garrido JM, Geijo M, Sevilla I, et al. Association
between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inﬂammatory bowel disease patients
and controls. Int J Infect Dis 2009;13(March (2)):247–54.
[3] Singh AV, Singh SV, Makharia GK, Singh PK, Sohal JS. Presence and characterization of Mycobacterium avium subspecies paratuberculosis from clinical and
suspected cases of Crohn’s disease and in the healthy human population in
India. Int J Infect Dis 2008;12(March (2)):190–7.
[4] USDA. Animal and Plant Health Inspection Service. Johne’s disease on U.S.
dairies. 1991–2007. Report; 2008.
[5] Sibartie S, Scully P, Keohane J, O’Neill S, O’Mahony J, O’Hanlon D, et al. Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn’s
disease. Inﬂamm Bowel Dis 2010;16(February (2)):296–304.
[6] Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG,
et al. Mycobacterium avium subspecies paratuberculosis in children with earlyonset Crohn’s disease. Inﬂamm Bowel Dis 2009;15(November (11)):1643–55.

[7] Lee A, Grifﬁths TA, Parab RS, King RK, Dubinsky MC, Urbanski SJ, et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn disease in
pediatric patients. J Pediatr Gastroenterol Nutr 2011;52(February (2)):170–4.
[8] Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium
subspecies paratuberculosis from the blood of patients with Crohn’s disease.
Lancet 2004;364(September (9439)):1039–44.
[9] Olsen I, Tollefsen S, Aagaard C, Reitan LJ, Bannantine JP, Andersen P, et al. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells
from intestinal biopsies of Crohn’s disease patients. PLoS One 2009;4(5):e5641.
[10] Chiappini E, de Martino M, Mangiantini F, Lionetti P. Crohn disease and
mycobacterial infection in children: an intriguing relationship. J Pediatr Gastroenterol Nutr 2009;49(November (5)):550–8.
[11] Allen AJ, Park KT, Barrington GM, Lahmers KK, Hamilton MJ, Davis WC. Development of a bovine ileal cannulation model to study the immune response
and mechanisms of pathogenesis of paratuberculosis. Clin Vaccine Immunol
2009;16(April (4)):453–63.
[12] Koo HC, Park YH, Hamilton MJ, Barrington GM, Davies CJ, Kim JB, et al.
Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves. Infect Immun 2004;72(December
(12)):6870–83.
[13] Stabel JR, Palmer MV, Harris B, Plattner B, Hostetter J, Robbe-Austerman
S. Pathogenesis of Mycobacterium avium subsp. paratuberculosis in neonatal calves after oral or intraperitoneal experimental infection. Vet Microbiol
2009;136(May (3–4)):306–13.
[14] Demangel C, Britton WJ. Interaction of dendritic cells with mycobacteria: where
the action starts. Immunol Cell Biol 2000;78(August (4)):318–24.
[15] Martino A. Mycobacteria and innate cells: critical encounter for immunogenicity. J Biosci 2008;33(March (1)):137–44.
[16] Niedergang F, Didierlaurent A, Kraehenbuhl JP, Sirard JC. Dendritic cells: the
host Achille’s heel for mucosal pathogens? Trends Microbiol 2004;12(February
(2)):79–88.
[17] Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and
regulatory T cells. J Clin Immunol 2008;28(November (6)):660–70.
[18] Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new
immunological and genetic insights implicate Th17 cells in the pathogenesis
of Crohn’s disease. Gut 2009;58(August (8)):1152–67.
[19] O’Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity
of helper CD4+ T cells. Science 2010;327(February (5969)):1098–102.
[20] Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal Malefyt R, Ottenhoff
TH, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by
human T cells. Eur J Immunol 2006;36(March (3)):661–70.
[21] Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ.
IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol
Rev 2004;202(December):96–105.
[22] Dhiman R, Indramohan M, Barnes PF, Nayak RC, Paidipally P, Rao LV, et al.
IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 2009;183(November
(10)):6639–45.
[23] Dieli F, Troye-Blomberg M, Ivanyi J, Fournie JJ, Krensky AM, Bonneville M, et al.
Granulysin-dependent killing of intracellular and extracellular Mycobacterium
tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 2001;184(October (8)):1082–5.
[24] Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the
arsenal. Nat Rev Immunol 2003;3(May (5)):361–70.
[25] Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta
T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J
Immunol 2006;177(October (7)):4662–9.
[26] Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, et al.
Cutting edge: regulatory T cells prevent efﬁcient clearance of Mycobacterium
tuberculosis. J Immunol 2007;178(March (5)):2661–5.
[27] Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. FoxP3+ regulatory T
cells suppress effector T-cell function at pathologic site in miliary tuberculosis.
Am J Respir Crit Care Med 2009;179(June (11)):1061–70.
[28] de Almeida DE, Colvin CJ, Coussens PM. Antigen-speciﬁc regulatory T cells
in bovine paratuberculosis. Vet Immunol Immunopathol 2008;125(October
(3–4)):234–45.
[29] Singh SV, Singh PK, Singh AV, Sohal JS, Sharma MC. Therapeutic effects of a
new “Indigenous Vaccine” developed using novel native “Indian Bison Type”
genotype of Mycobacterium avium subspecies paratuberculosis for the control
of clinical Johne’s disease in naturally infected goatherds in India. Vet Med Int
2010;2010:351846.
[30] Juste RA, Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla IA, et al. Signiﬁcant reduction in bacterial shedding and improvement in milk production
in dairy farms after the use of a new inactivated paratuberculosis vaccine in a
ﬁeld trial. BMC Res Notes 2009;2:233.
[31] Reddacliff L, Eppleston J, Windsor P, Whittington R, Jones S. Efﬁcacy of a killed
vaccine for the control of paratuberculosis in Australian sheep ﬂocks. Vet Microbiol 2006;115(June (1–3)):77–90.
[32] Kathaperumal K, Kumanan V, McDonough S, Chen LH, Park SU, Moreira MA,
et al. Evaluation of immune responses and protective efﬁcacy in a goat model
following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis. Vaccine 2009;27(January
(1)):123–35.
[33] Scandurra GM, de Lisle GW, Cavaignac SM, Young M, Kawakami RP, Collins DM.
Assessment of live candidate vaccines for paratuberculosis in animal models
and macrophages. Infect Immun 2010;78(March (3)):1383–9.

K.T. Park et al. / Vaccine 29 (2011) 4709–4719
[34] Shin SJ, Wu CW, Steinberg H, Talaat AM. Identiﬁcation of novel virulence determinants in Mycobacterium paratuberculosis by screening a library of insertional
mutants. Infect Immun 2006;74(July (7)):3825–33.
[35] Harris NB, Feng Z, Liu X, Cirillo SL, Cirillo JD, Barletta RG. Development of a transposon mutagenesis system for Mycobacterium avium subsp. paratuberculosis.
FEMS Microbiol Lett 1999;175(June (1)):21–6.
[36] Park KT, Dahl JL, Bannantine JP, Barletta RG, Ahn J, Allen AJ, et al. Demonstration
of allelic exchange in the slow-growing bacterium Mycobacterium avium subsp.
paratuberculosis, and generation of mutants with deletions at the pknG, relA,
and lsr2 loci. Appl Environ Microbiol 2008;74(March (6)):1687–95.
[37] Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, et al. The role of
RelMtb-mediated adaptation to stationary phase in long-term persistence of
Mycobacterium tuberculosis in mice. Proc Natl Acad Sci U S A 2003;100(August
(17)):10026–31.
[38] Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K,
et al. Protein kinase G from pathogenic mycobacteria promotes survival within
macrophages. Science 2004;304(June (5678)):1800–4.
[39] Colangeli R, Helb D, Vilcheze C, Hazbon MH, Lee CG, Saﬁ H, et al. Transcriptional
regulation of multi-drug tolerance and antibiotic-induced responses by the
histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog 2007;3(June (6)):e87.
[40] Hines 2nd ME, Stabel JR, Sweeney RW, Grifﬁn F, Talaat AM, Bakker D, et al.
Experimental challenge models for Johne’s disease: a review and proposed
international guidelines. Vet Microbiol 2007;122(June (3–4)):197–222.
[41] Harris NB, Zinniel DK, Hsieh MK, Cirillo JD, Barletta RG. Cell sorting of
formalin-treated pathogenic Mycobacterium paratuberculosis expressing GFP.
Biotechniques 2002;32(March (3)):522–4, 6–7.
[42] Woo SR, Sotos J, Hart AP, Barletta RG, Czuprynski CJ. Bovine monocytes and a
macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis. Vet Immunol
Immunopathol 2006;110(March (1–2)):109–20.
[43] Greig A, Stevenson K, Perez V, Pirie AA, Grant JM, Sharp JM. Paratuberculosis in
wild rabbits (Oryctolagus cuniculus). Vet Rec 1997;140(February (6)):141–3.
[44] Schonenbrucher H, Abdulmawjood A, Failing K, Bulte M. New triplex realtime PCR assay for detection of Mycobacterium avium subsp. paratuberculosis
in bovine feces. Appl Environ Microbiol 2008;74(May (9)):2751–8.
[45] Irenge LM, Walravens K, Govaerts M, Godfroid J, Rosseels V, Huygen K, et al.
Development and validation of a triplex real-time PCR for rapid detection and
speciﬁc identiﬁcation of M. avium subsp. paratuberculosis in faecal samples. Vet
Microbiol 2009;136(April (1–2)):166–72.
[46] Coussens PM, Verman N, Coussens MA, Elftman MD, McNulty AM. Cytokine
gene expression in peripheral blood mononuclear cells and tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis: evidence
for an inherent proinﬂammatory gene expression pattern. Infect Immun
2004;72(March (3)):1409–22.
[47] Primm TP, Andersen SJ, Mizrahi V, Avarbock D, Rubin H, Barry 3rd CE. The stringent response of Mycobacterium tuberculosis is required for long-term survival.
J Bacteriol 2000;182(September (17)):4889–98.

4719

[48] Rifat D, Bishai WR, Karakousis PC. Phosphate depletion: a novel trigger
for Mycobacterium tuberculosis persistence. J Infect Dis 2009;200(October
(7)):1126–35.
[49] Ulrichs T, Kaufmann SH. Mycobacterial persistence and immunity. Front Biosci
2002;7(February):d458–69.
[50] Spira B, Silberstein N, Yagil E. Guanosine 3 ,5 -bispyrophosphate (ppGpp)
synthesis in cells of Escherichia coli starved for Pi. J Bacteriol 1995;177(July
(14)):4053–8.
[51] Dean RE, Ireland PM, Jordan JE, Titball RW, Oyston PC. RelA regulates
virulence and intracellular survival of Francisella novicida. Microbiology
2009;155(December (Pt 12)):4104–13.
[52] Curtis MM, Way SS, Wilson CB. IL-23 promotes the production of IL-17 by
antigen-speciﬁc CD8 T cells in the absence of IL-12 and type-I interferons. J
Immunol 2009;183(July (1)):381–7.
[53] Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al.
Human IL-23-producing type 1 macrophages promote but IL-10-producing
type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U
S A 2004;101(March (13)):4560–5.
[54] Gansert JL, Kiessler V, Engele M, Wittke F, Rollinghoff M, Krensky AM, et al.
Human NKT cells express granulysin and exhibit antimycobacterial activity. J
Immunol 2003;170(March (6)):3154–61.
[55] Olsen I, Boysen P, Kulberg S, Hope JC, Jungersen G, Storset AK. Bovine NK
cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70. Infect Immun
2005;73(September (9)):5628–35.
[56] Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT
cells recognize Mycobacterium tuberculosis-infected macrophages, produce
interferon-gamma, and kill intracellular bacteria. PLoS Pathog 2008;4(December (12)):e1000239.
[57] Tewary P, Yang D, de la Rosa G, Li Y, Finn MW, Krensky AM, et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.
Blood 2010;116(November (18)):3465–74.
[58] Capinos Scherer CF, Endsley JJ, de Aguiar JB, Jacobs Jr WR, Larsen MH, Palmer
MV, et al. Evaluation of granulysin and perforin as candidate biomarkers
for protection following vaccination with Mycobacterium bovis BCG or M.
bovisDeltaRD1. Transbound Emerg Dis 2009;56(August (6–7)):228–39.
[59] Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin
E(2) in articular cartilage explants. Osteoarthr Cartilage 2005;13(May (5)):
387–94.
[60] Seo KS, Lee SU, Park YH, Davis WC, Fox LK, Bohach GA. Long-term staphylococcal
enterotoxin C1 exposure induces soluble factor-mediated immunosuppression by bovine CD4+ and CD8+ T cells. Infect Immun 2007;75(January (1)):
260–9.
[61] Evans AC, Ireland JL, Winn ME, Lonergan P, Smith GW, Coussens PM, et al. Identiﬁcation of genes involved in apoptosis and dominant follicle development
during follicular waves in cattle. Biol Reprod 2004;70(May (5)):1475–84.

